Please assess the completion status of the following clinical trial:

Trial Title: Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Key Inclusion Criteria for participants enrolling with T2DM:~* Type 2 Diabetes treated with a stable dose of metformin at least 500 mg per day for at least 2 months prior to screening visit and use of no other medications for glycemic control.~* HbA1c value between 7.0% and 10.5%, inclusive.~Key Exclusion Criterion for participants enrolling with T2DM:~-Type 1 Diabetes or secondary forms of diabetes.~Key Inclusion Criterion for participants enrolling with obesity:~-Obese (as indicated by screening BMI) non-diabetic adults.~Key Exclusion Criterion for participants enrolling with obesity:~--Type 1 or Type 2 Diabetes or secondary forms of diabetes.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Active Obesity (Type: EXPERIMENTAL): Part B
- Placebo Obesity (Type: PLACEBO_COMPARATOR): Part B
- Active T2DM (Type: EXPERIMENTAL): Parts A and C
- Placebo T2DM (Type: PLACEBO_COMPARATOR): Parts A and C

Based on this trial design, predict the completion outcome and termination type (if applicable).